In this context, we propose that immunization with linked sets of antigens (e.g., TIF1-γ, CCAR-1, or the other autoantigens) associated with cancer protection as defined in this study might be harnessed in novel prevention and therapeutic approaches to cancer, particularly in high-risk groups. This evidence concerns the gene CCAR1 and cancer.